Literature DB >> 393438

Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.

G M Vergani, D Vergani, P J Jenkins, B Portmann, A P Mowat, A L Eddleston, R Williams.   

Abstract

In a micrototoxicity assay, lymphocytes from ten out of sixteen patients with HBsAg-negative chronic active hepatitis have been shown to be cytotoxic to autologous hepatocytes isolated from percutaneous liver biopsies. This cytoxicity was demonstrable in all six untreated patients but in only four out of ten receiving immunosuppressive treatment, the presence of cytotoxicity showing a significant association with the activity of the disease assessed histologically. The addition of excess purified lipoprotein (LSP), derrived from the hepatocyte plasma membrane, blocked the reaction in all cytotoxic cases, indicating that LSP was the major target antigen. Enriched fractions of T cells were cytotoxic in only one case, whereas non-T cell fractions were cytotoxic in the other ten cases investigated in this way. For optimum T cell cytotoxicity, effector and target cells must share histocompatibility determinants and the results of this study using an autologous system show conclusively that the lymphocyte cytotoxicity found in HBsAg-negative chronic active hepatitis is mediated by a non-T cell population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393438      PMCID: PMC1537835     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Innate cytotoxicity of CBA mouse spleen cells to Sendai virus-infected L cells.

Authors:  M J Anderson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

2.  Functional correlation between antibody-dependent and spontaneous cytotoxic activity of human lymphocytes and possibility of an HLA-related control.

Authors:  G Trinchieri; D Santoli; C M Zmijewski; H Koprowski
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

5.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde
Journal:  Br J Exp Pathol       Date:  1974-10

6.  "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

Authors:  R Kiessling; E Klein; H Pross; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

7.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

8.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.

Authors:  A M Cochrane; A Moussouros; A Smith; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

10.  Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.

Authors:  D Santoli; G Trinchieri; L Moretta; C M Zmijewski; H Koprowski
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

View more
  35 in total

Review 1.  Immunological aspects of liver disease.

Authors:  A L Eddleston; P T Donaldson; J E Hegarty; B D Reed
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Springer Semin Immunopathol       Date:  1990

Review 4.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

Review 5.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

6.  In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.

Authors:  M Mondelli; A Alberti; F Tremolada; R Williams; A L Eddleston; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 7.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  Studies on experimental chronic active hepatitis in the rabbit. II. Immunological findings.

Authors:  R C Butler
Journal:  Br J Exp Pathol       Date:  1984-08

9.  Studies on experimental chronic active hepatitis in the rabbit. I. Induction of the disease by immunization with muscle as well as liver proteins.

Authors:  R C Butler
Journal:  Br J Exp Pathol       Date:  1984-08

10.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.